factual
Asacol Delzicol Useless Capsule Blocked Generics
In the Asacol/Delzicol case the company introduced a new patented product identical to the old drug except for an ineffective capsule that did nothing, then withdrew the original Asacol from the market; because pharmacists could not substitute a generic of the now-unavailable original, and generics could not add a matching capsule without infringing the new patent, the maneuver blocked generic competition despite the change being therapeutically meaningless.
factualpending
Speaker
Robin FeldmanEvidence Quote
“it introduced a new product, which was the same drug except with an ineffective capsule around it... Even the FDA agreed that the two drugs were exactly the same.”
Created: 6/13/2026, 12:11:23 AM
Your notes
Loading notes...